These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]
15. Results of a prospective study for the treatment of retinoblastoma. Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E. Cancer; 2004 Feb 15; 100(4):834-42. PubMed ID: 14770442 [Abstract] [Full Text] [Related]
17. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Shields CL, Shelil A, Cater J, Meadows AT, Shields JA. Arch Ophthalmol; 2003 Nov 15; 121(11):1571-6. PubMed ID: 14609913 [Abstract] [Full Text] [Related]
19. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG. Ophthalmology; 2007 Jan 15; 114(1):162-9. PubMed ID: 17070578 [Abstract] [Full Text] [Related]
20. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma. Ye H, Du Y, Chen R, Luo X, Mao Y, Ai S, Ma W, Ding Y, Li Q, Yang H. Curr Eye Res; 2016 Nov 15; 41(11):1507-1512. PubMed ID: 27158739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]